Lao People's Democratic Republic vs Mexico: The number of people with susceptibility test result for rifampicin
Lao People's Democratic Republic
3,796
in 2021
Mexico
4,205
in 2021
Lao People's Democratic Republic rank
36th
Mexico rank
34th
The number of people with susceptibility test result for rifampicin over time
- Lao People's Democratic Republic
- Mexico
How they compare
Mexico currently reports 4,205 against 3,796 in Lao People's Democratic Republic, a difference of 409.
That makes Mexico's figure about 1.1 times Lao People's Democratic Republic's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Lao People's Democratic Republic ahead.
Lao People's Democratic Republic ranks 36th and Mexico ranks 34th of 155 countries.
Lao People's Democratic Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,477 | 183.67 | 2,293 | Lao People's Democratic Republic |
| 2020s | 3,803 | 3,240 | 563 | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Lao People's Democratic Republic or Mexico?
- Mexico, at 4,205 against 3,796 in Lao People's Democratic Republic as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Lao People's Democratic Republic and Mexico?
- 409, with Mexico ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Mexico?
- 5 years are reported by both, from 2017 to 2021.
- How do Lao People's Democratic Republic and Mexico rank globally for the number of people with susceptibility test result for rifampicin?
- Lao People's Democratic Republic ranks 36th and Mexico ranks 34th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.